Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.

Oba A, Ban D, Kirimura S, Akahoshi K, Mitsunori Y, Matsumura S, Ochiai T, Kudo A, Tanaka S, Minoru T. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2016 Aug; 23(8):480-8.

View in: PubMed

subject areas

Adenocarcinoma
Aged
Aged, 80 and over
Biomarkers, Tumor
Biopsy, Needle
Carcinoma, Pancreatic Ductal
Chemotherapy, Adjuvant
Cohort Studies
Deoxycytidine
Disease-Free Survival
Drug Combinations
Female
Hospitals, University
Humans
Immunohistochemistry
Japan
Kaplan-Meier Estimate
Lymph Nodes
Male
Middle Aged
Oxonic Acid
Pancreatectomy
Pancreatic Neoplasms
Patient Selection
Precision Medicine
Prognosis
Proportional Hazards Models
Retrospective Studies
Risk Assessment
Statistics, Nonparametric
Survival Rate
Tegafur

authors with profiles

Atsushi Oba